中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2013年
12期
2707-2708
,共2页
王海斌%黄昕%王任之%梁小波%黄杰%徐飞鹏
王海斌%黃昕%王任之%樑小波%黃傑%徐飛鵬
왕해빈%황흔%왕임지%량소파%황걸%서비붕
基质金属蛋白酶-9%胃癌
基質金屬蛋白酶-9%胃癌
기질금속단백매-9%위암
Matrix metalloproteinase-9%Gastric carcinoma
目的 观察胃癌患者血清基质金属蛋白酶-9 (MMP-9)的表达,探讨其临床价值.方法 应用酶联免疫吸附试验(ELISA)法测定60例胃癌患者、30例正常人血清MMP-9水平,对36例胃癌患者手术前后血清MMP-9水平进行比较.结果 胃癌患者血清MMP-9水平[(60.44±9.75) μg/L]明显高于正常对照组[(26.79±2.65) μg/L],两者比较差异有统计学意义(P<0.01);血清MMP-9水平与胃癌患者性别、年龄和癌细胞分化程度无相关;血清MMP-9水平与胃癌患者临床分期有关,Ⅳ期[(72.47±4.21) μg/L]明显高于Ⅲ期[(65.73±4.36) μg/L]、Ⅲ期[(65.73±4.36)μg/L]明显高于Ⅱ期[(54.89±3.73)μg/L]、Ⅱ期[(54.89±3.73)μg/L]明显高于Ⅰ期[(48.42±3.89) μg/L]、两两比较差异有统计学意义(P<0.05);手术后胃癌患者血清MMP-9水平[(6.89±1.27) μg/L]明显低于患者手术前[(7.19±1.26)μg/L],两者差异有统计学意义(P<0.01).结论 MMP-9可作为反映胃癌疾病进展的分子标志物之一.
目的 觀察胃癌患者血清基質金屬蛋白酶-9 (MMP-9)的錶達,探討其臨床價值.方法 應用酶聯免疫吸附試驗(ELISA)法測定60例胃癌患者、30例正常人血清MMP-9水平,對36例胃癌患者手術前後血清MMP-9水平進行比較.結果 胃癌患者血清MMP-9水平[(60.44±9.75) μg/L]明顯高于正常對照組[(26.79±2.65) μg/L],兩者比較差異有統計學意義(P<0.01);血清MMP-9水平與胃癌患者性彆、年齡和癌細胞分化程度無相關;血清MMP-9水平與胃癌患者臨床分期有關,Ⅳ期[(72.47±4.21) μg/L]明顯高于Ⅲ期[(65.73±4.36) μg/L]、Ⅲ期[(65.73±4.36)μg/L]明顯高于Ⅱ期[(54.89±3.73)μg/L]、Ⅱ期[(54.89±3.73)μg/L]明顯高于Ⅰ期[(48.42±3.89) μg/L]、兩兩比較差異有統計學意義(P<0.05);手術後胃癌患者血清MMP-9水平[(6.89±1.27) μg/L]明顯低于患者手術前[(7.19±1.26)μg/L],兩者差異有統計學意義(P<0.01).結論 MMP-9可作為反映胃癌疾病進展的分子標誌物之一.
목적 관찰위암환자혈청기질금속단백매-9 (MMP-9)적표체,탐토기림상개치.방법 응용매련면역흡부시험(ELISA)법측정60례위암환자、30례정상인혈청MMP-9수평,대36례위암환자수술전후혈청MMP-9수평진행비교.결과 위암환자혈청MMP-9수평[(60.44±9.75) μg/L]명현고우정상대조조[(26.79±2.65) μg/L],량자비교차이유통계학의의(P<0.01);혈청MMP-9수평여위암환자성별、년령화암세포분화정도무상관;혈청MMP-9수평여위암환자림상분기유관,Ⅳ기[(72.47±4.21) μg/L]명현고우Ⅲ기[(65.73±4.36) μg/L]、Ⅲ기[(65.73±4.36)μg/L]명현고우Ⅱ기[(54.89±3.73)μg/L]、Ⅱ기[(54.89±3.73)μg/L]명현고우Ⅰ기[(48.42±3.89) μg/L]、량량비교차이유통계학의의(P<0.05);수술후위암환자혈청MMP-9수평[(6.89±1.27) μg/L]명현저우환자수술전[(7.19±1.26)μg/L],량자차이유통계학의의(P<0.01).결론 MMP-9가작위반영위암질병진전적분자표지물지일.
Objective To investigate the level of serum matrix metalloproteinase-9 (MMP-9) in patients with gastric carcinoma and study its clinical value.Methods Serum MMP-9 were detected with Enzyme linked immunosorbent assay (ELISA) in 60 cases of patients with gastric carcinoma and 30 cases of normal control subject,compared with 36 cases of patients with gastric carcinoma pre-and post-operation.Results The level of serum MMP-9 elevated in all subgroups of patients with gastric carcinoma (60.44 ± 9.75) μg/L was higher than that in the controls (26.79 ± 2.65) μg/L (P < 0.01),serum MMP-9 was not correlated with sex,age and histological grade; serum MMP-9 was correlated with TNM stage,the serum MMP-9 level in stage Ⅳ (72.47 ±4.21) μg/L was higher in comparison with stage Ⅲ (65.73 ±4.36) μg/L (P <0.01),in stage Ⅲ (65.73 ±4.36) μg/L it was I higher than that in stage Ⅱ (54.89 ± 3.73) μg/L (P < 0.01),in stage Ⅱ (54.89 ± 3.73) μg/L it was higher than that in stage Ⅰ (48.42 ± 3.89) μg/L (P < 0.05),the serum MMP-9 levels were remarkably decreased in patients with gastric carcinoma after operation (P < 0.01).Conclusion MMP-9 may be used as a molecular marker to assess of the disease status of gastric carcinoma.